Previous 10 | Next 10 |
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company will begin prese...
RenovaCare (RCAR) elects CEO and President Alan L. Rubino for the additional role of Chairman, effective Oct. 1, 2020.The appointment comes after the resignation of former Chairman Harmel S. Rayat on the same date. Addressing his departure from the company, Mr. Rayat notes...
ROSELAND, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that Alan L. Rubino, Chief Executive Officer and President, h...
ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company will present ...
Ultra-thinly traded micro cap RennovaCare ( OTCPK:RCAR +18.6% ) is up almost a 5x surge in volume, albeit on turnover of only 87K shares, in reaction to its announcement that the FDA has conditionally signed off on a clinical trial evaluating autologous stem cells rendered by its CellMis...
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the US Food and Drug Administrati...
ROSELAND, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the appointment of Lydia M. E...
ROSELAND, N.J., July 01, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the official launch of its new RenovaCare R&D Innovation Center in Berlin, Germany, where the Company’s patented technologies for isolating and spraying self-d...
ROSELAND, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the appointment of new Chief Finan...
ROSELAND, N.J., June 10, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the appointment of its first Chief...
News, Short Squeeze, Breakout and More Instantly...
Spark New Zealand Limited ADR (SPKKY) is expected to report for Q1 2024 Taylor Devices Inc. (TAYD) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for Q3 2024 ...
1st Cap Bancorp (FISB) is expected to report for Q3 2023 Timberline Resources Corp. (TLRS) is expected to report for Q1 2024 Engie Brasil Energia S.A. ADR (EGIEY) is expected to report for Q4 2023 NuZee Inc. (NUZE) is expected to report for quarter end 2023-09-30 Global Arena Hold...
Bexil Corp (BXLC) is expected to report for quarter end 2023-09-30 Daily Journal Corp. (S.C.) (DJCO) is expected to report for quarter end 2023-09-30 Arch Therapeutics Inc (ARTH) is expected to report $-0.13 for Q4 2023 First Republic Bank (San Francisco, California) (FRCB) is expecte...